Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

Authors: J C JC. Strefford, L L. Kadalayil, J J. Forster, M J J MJ. Rose-Zerilli, A A. Parker, T T TT. Lin, N N. Heppel, K K. Norris, A A. Gardiner, Z Z. Davies, D D. Gonzalez de Castro, M M. Else, A J AJ. Steele, H H. Parker, T T. Stankovic, C C. Pepper, C C. Fegan, D D. Baird, A A. Collins, D D. Catovsky, D G DG. Oscier
Published: 08/10/2015, Leukemia